(CercleFinance.com) – On the occasion of the publication of its quarterly reports, AbbVie announces a 5% increase in its dividend for 2023, thus fixing the quarterly installment at 1.48 dollars per share, starting from the dividend which will be payable next February.
In its third quarter, the pharmaceutical group achieved an adjusted EPS of 3.66 dollars, up 29.3%, for net sales of 14.8 billion, up 3.3% in published data. and 5.4% operationally.
For 2022 as a whole, AbbVie confirms the midpoint of its guidance range for adjusted EPS, while tightening that range to between $13.84 and $13.88, from $13.76 to $13.96 as previously indicated.
Copyright © 2022 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
